530 related articles for article (PubMed ID: 25389999)
1. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.
López-Jaramillo P; Gómez-Arbeláez D; López-López J; López-López C; Martínez-Ortega J; Gómez-Rodríguez A; Triana-Cubillos S
Horm Mol Biol Clin Investig; 2014 Apr; 18(1):37-45. PubMed ID: 25389999
[TBL] [Abstract][Full Text] [Related]
2. Association of selected adipokines with metabolic syndrome and cardio-metabolic risk factors in young males.
Ouerghi N; Ben Fradj MK; Talbi E; Bezrati I; Feki M; Bouassida A
Cytokine; 2020 Sep; 133():155170. PubMed ID: 32554156
[TBL] [Abstract][Full Text] [Related]
3. [The adiponectin to leptin ratio, a still unrecognized biomarker of insulin resistance and cardiometabolic risk].
Vatier C; Antuna-Puente B; Fellahi S; Vigouroux C; Capeau J; Bastard JP;
Ann Biol Clin (Paris); 2020 Jun; 78(3):265-268. PubMed ID: 32420886
[TBL] [Abstract][Full Text] [Related]
4. Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
Supriya R; Tam BT; Yu AP; Lee PH; Lai CW; Cheng KK; Yau SY; Chan LW; Yung BY; Sheridan S; Siu PM
PLoS One; 2018; 13(8):e0201585. PubMed ID: 30114249
[TBL] [Abstract][Full Text] [Related]
5. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country.
Barbosa-Cortés L; López-Alarcón M; Mejía-Aranguré JM; Klünder-Klünder M; Del Carmen Rodríguez-Zepeda M; Rivera-Márquez H; de la Vega-Martínez A; Martin-Trejo J; Shum-Luis J; Solis-Labastida K; López-Aguilar E; Matute-González G; Bernaldez-Rios R
BMC Cancer; 2017 Feb; 17(1):125. PubMed ID: 28193268
[TBL] [Abstract][Full Text] [Related]
6. The link between abdominal obesity and the metabolic syndrome.
Phillips LK; Prins JB
Curr Hypertens Rep; 2008 Apr; 10(2):156-64. PubMed ID: 18474184
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk.
Frühbeck G; Catalán V; Rodríguez A; Gómez-Ambrosi J
Adipocyte; 2018 Jan; 7(1):57-62. PubMed ID: 29205099
[TBL] [Abstract][Full Text] [Related]
8. Overweight and obesity: the pathogenesis of cardiometabolic risk.
Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
[TBL] [Abstract][Full Text] [Related]
9. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
Kopff B; Jegier A
Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
[TBL] [Abstract][Full Text] [Related]
10. Expression of leptin, NGF and adiponectin in metabolic syndrome.
Atanassova P; Hrischev P; Orbetzova M; Nikolov P; Nikolova J; Georgieva E
Folia Biol (Krakow); 2014; 62(4):301-6. PubMed ID: 25916157
[TBL] [Abstract][Full Text] [Related]
11. Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome.
Ahirwar AK; Jain A; Goswami B; Bhatnagar MK; Bhatacharjee J
Diabetes Metab Syndr; 2014; 8(3):152-5. PubMed ID: 25042166
[TBL] [Abstract][Full Text] [Related]
12. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
13. Guiding clinical decisions on abdominal obesity and cardiometabolic risk.
Nesto RW; Nelinson DS; Pagotto U
Clin Cornerstone; 2009; 9(4):43-52; discussion 53-4. PubMed ID: 19789063
[TBL] [Abstract][Full Text] [Related]
14. The role of adiponectin signaling in metabolic syndrome and cancer.
Scheid MP; Sweeney G
Rev Endocr Metab Disord; 2014 Jun; 15(2):157-67. PubMed ID: 24019064
[TBL] [Abstract][Full Text] [Related]
15. An Overview of the Role of Adipokines in Cardiometabolic Diseases.
Farkhondeh T; Llorens S; Pourbagher-Shahri AM; Ashrafizadeh M; Talebi M; Shakibaei M; Samarghandian S
Molecules; 2020 Nov; 25(21):. PubMed ID: 33182462
[TBL] [Abstract][Full Text] [Related]
16. Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.
Kukla M; Mazur W; Bułdak RJ; Zwirska-Korczala K
Mol Med; 2011; 17(11-12):1397-410. PubMed ID: 21738955
[TBL] [Abstract][Full Text] [Related]
17. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk.
Calabro P; Yeh ET
Curr Hypertens Rep; 2008 Feb; 10(1):32-8. PubMed ID: 18367024
[TBL] [Abstract][Full Text] [Related]
18. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
20. Adipokines, metabolic syndrome and rheumatic diseases.
Abella V; Scotece M; Conde J; López V; Lazzaro V; Pino J; Gómez-Reino JJ; Gualillo O
J Immunol Res; 2014; 2014():343746. PubMed ID: 24741591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
